AstraZeneca lupus drug fails to meet main goal in study
(Reuters) – AstraZeneca’s experimental drug anifrolumab failed to meet its main target in a late-stage clinical study treating patients with moderate to severe lupus, the British drugmaker said on Friday. AstraZeneca...
Read More